PRESS RELEASE published on 10/04/2023 at 14:01, 1 year 1 month ago Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania
PRESS RELEASE published on 09/27/2023 at 14:01, 1 year 1 month ago Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology
PRESS RELEASE published on 09/20/2023 at 09:01, 1 year 2 months ago Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference
PRESS RELEASE published on 09/13/2023 at 09:01, 1 year 2 months ago Mainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA Biomarkers, Reports Groundbreaking Topline Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advance
PRESS RELEASE published on 09/05/2023 at 09:01, 1 year 2 months ago Mainz Biomed Announces Strategic Partnership with Ärztliches Labor Dr. Buhlmann, Expanding Footprint in German Market
PRESS RELEASE published on 08/29/2023 at 09:01, 1 year 2 months ago Mainz Biomed to Present at the H.C. Wainwright Global Investment Conference
PRESS RELEASE published on 08/15/2023 at 09:01, 1 year 3 months ago Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update
PRESS RELEASE published on 08/01/2023 at 09:01, 1 year 3 months ago Mainz Biomed Announces Live Launch of ColoAlert® with Marylebone Laboratory in the United Kingdom
PRESS RELEASE published on 07/18/2023 at 09:01, 1 year 4 months ago Mainz Biomed Announces Collaboration with Fugene Genetics in Israel
PRESS RELEASE published on 06/29/2023 at 09:01, 1 year 4 months ago Mainz Biomed Secures up to $50M in New Funding
Published on 11/22/2024 at 00:00, 5 hours 40 minutes ago Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 7 hours 35 minutes ago Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 7 hours 50 minutes ago Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 9 hours 25 minutes ago Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 9 hours 30 minutes ago For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform
Published on 11/21/2024 at 19:01, 10 hours 38 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 11 hours 4 minutes ago Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 11 hours 41 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 11 hours 48 minutes ago LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 11 hours 48 minutes ago 2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.
Published on 11/21/2024 at 06:58, 22 hours 42 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 10 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 11 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 11 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 21 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
